| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Acer Therapeutics Inc. | Chief Commercial Officer | Employee Stock Option (right to buy) | 25,000 | 14 Jan 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| /report/000120919122003732-seibt-matthew-2022-01-14 | Acer Therapeutics Inc. | 14 Jan 2022 | 1 | $0 | 4 | Chief Commercial Officer | 19 Jan 2022, 15:32 |